Cathy Eng, VICC Associate Director of Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer Center, shared a post on X:
“Updated data from Dr. Purvl Shah re: BESPOKE trial re: role of ctDNA and the impact on decision making in stage II/III colon cancer disease.”
